UFP Technologies just smashed Q2 2026 earnings, raking in $174M in sales—15.1% up from last year and beating forecasts—with profits per share also exceeding expectations. Since 1963, this healthcare tech specialist has delivered stellar growth, compounding revenue at 27.5% annually over five years, even as recent momentum slowed. Even more impressively, EPS has surged 36.7% yearly, proving they’re scaling smarter, not just bigger, with a steady 16% operating margin. Analysts now see modest 4.3% growth ahead, hinting at headwinds—but the stock’s post-earnings bump underscores that long-term strength, not short-term spikes, is what really moves investors.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
